ABOUT OGO
Jiangsu OGO Biotechnology Co., Ltd. was founded in 2008 and is headquartered in the Economic Development Zone of Liyang City, Jiangsu Province. Leveraging its robust overall capabilities, the company has earned numerous certifications and accolades, including designation as a National High-Tech Enterprise, a Jiangsu Provincial Technological Innovation Enterprise, a Provincial Enterprise Technology Center, and a Provincial Private Science and Technology Enterprise. It is also recognized as a “Little Giant” enterprise specializing in niche markets and demonstrating exceptional innovation, as well as a Gazelle Enterprise.
The company focuses on two core business areas: first, the bioenzymatic production of functional sugars, which are widely used in the food, pharmaceutical excipient, and feed industries; and second, the synthesis-biological production of bioactive compounds such as amino acids, nucleotides, and vitamins, serving the pharmaceutical raw materials, intermediates, and animal nutrition sectors. Leveraging its technological strengths, the company has established a diversified product portfolio, with several products consistently holding leading positions in the industry.
Company Establishment
The company holds patent applications.
Company employees
In the functional sugars segment, the core products include trehalose, maltose, isomaltulose, polydextrose, cyclodextrins, and complex starch sugars. Notably, the company holds the world’s largest production capacity for trehalose, with the 200,000-ton trehalose production line at Heilongjiang Xianggu successfully commissioned in 2025. The company is also the only domestic producer capable of manufacturing maltose powder with a purity exceeding 90%, and as the largest β-cyclodextrin producer in China, its products enjoy exceptionally high market recognition.
Amino acid products include L-phenylalanine, γ-aminobutyric acid, L-2-aminobutyric acid, valine, arginine, and others, all manufactured with dedicated expertise by Jilin Jia’ao. Benefiting from their high purity and exceptional stability, these products are widely used in the pharmaceutical and dietary supplement industries.
In the nucleotide and bioactive substances sector, the company is one of China’s largest NMN (nicotinamide mononucleotide) producers, with an annual output capacity of 300 metric tons following a production-capacity upgrade. In addition, the company manufactures bioenzyme preparations, inositol, α-cyclodextrin, sodium/calcium gluconate, and other products. Its enzyme preparations are developed and produced in-house, while its inositol and α-cyclodextrin have obtained multiple international certifications and are successfully applied in feed, cosmetics, and other industries.
Technology Research and Development and Qualification Certification
Technical Team
The company regards technological innovation as its core competitive advantage and has established a technology system centered on bioenzyme technology as its core platform and synthetic biology as its development direction. It has independently mastered key technologies such as biofermentation process optimization, high-value utilization of by-products, and bioenzyme engineering. The R&D team is highly capable, with core members hailing from prestigious institutions such as Tsinghua University and Jiangnan University; the team comprises more than 50 R&D personnel, providing robust support for technological breakthroughs.
Intellectual Property
The company boasts a robust intellectual property portfolio, with a total of 175 patents (including 10 invention patents), as well as 15 trademarks and 1 copyright. It has successfully broken international technology monopolies in core products such as trehalose and cyclodextrins. In addition, the company actively engages in industry–university–research collaboration, jointly establishing talent-development centers with Jiangnan University and Jiangsu University. Focusing on more than 20 R&D projects—including γ-cyclodextrin, resistant dextrin, and novel candied fruits—the company continuously drives technological iteration and upgrading.
Qualification Certification
The company has a comprehensive certification system: domestically, it has obtained numerous certifications, including ISO 9001 (quality management), ISO 14001 (environmental management), ISO 22000 (food safety), HACCP, FSSC 22000, FAMI-QS (feed safety), and GMP (pharmaceutical excipients); internationally, it has secured HALAL and KOSHER certifications, ensuring compliance for product exports. In September 2025, the company completed the filing for “solely selling pre-packaged food” and simultaneously holds licenses for the production and sale of feed additives, food products, and pharmaceutical excipients, enabling compliant and orderly business operations.
Market Collaboration and Application Areas
Leveraging high-quality products and services, the company has established a stable collaborative ecosystem, with strategic clients including renowned enterprises such as Cargill in the United States and Xiangyu Group, with whom it has forged long-term strategic partnerships. At the same time, the company has deepened its presence in niche segments, cultivating close partnerships with industry-leading customers like Liuliu Orchard, Three Squirrels, and Mimosa, thereby earning a strong market reputation. In addition, the company continues to strengthen university–enterprise collaboration, engaging in in-depth cooperation with Jiangnan University and Jiangsu University on talent development and technological R&D, thus achieving synergistic development among industry, academia, and research.
In the food and beverage sector, products such as trehalose and isomaltulose are widely used as low- or no-sugar alternatives in baked goods, meat products, confectionery, frozen foods, and beverages. NMN and glutathione are employed as pharmaceutical and nutritional supplements, while β-cyclodextrin serves as a pharmaceutical excipient, thereby supporting the development of the pharmaceutical and health industries. In the animal nutrition field, ingredients like inositol, gamma-aminobutyric acid, and feed-grade amino acids are utilized as feed additives that effectively enhance animal health and growth performance, earning widespread recognition within the livestock industry.
The products are widely applied across three core sectors: food and beverage, pharmaceuticals and healthcare, and animal nutrition.
Corporate Culture and Governance
Creating an Innovative Cooperation Model for a “Community of Free Individuals”
The company positions itself as a platform-based enterprise, breaking down traditional organizational boundaries and leveraging an integrated management service platform to streamline front-end operations, enhance efficiency, and reduce burdens. It has pioneered an innovative collaborative model—the “Union of Autonomous Individuals”—to harness collective team synergy. In terms of governance, the company has implemented a business-unit management structure combined with a business-partner system, enabling closed-loop management across business units. By adopting a collaboration model based on shared benefits and shared risks, it deeply aligns individual growth with corporate development, thereby energizing the organization.
The company upholds the core values of “sincerity, innovation, collaboration, and win-win,” adheres to an integrity-based business philosophy, drives development through innovation, harnesses collective strength through collaboration, and strives for mutually beneficial growth among the enterprise, its employees, partners, and society. In terms of talent management, the company provides ample opportunities for career development and clear promotion pathways, places great emphasis on talent training and development, fosters a dynamic and innovative team culture, actively recruits young professionals committed to career success, and works together to build high-caliber teams.
Development History
2008–2011
Company Establishment
2012–2015
Extending downstream to break the international technology monopoly, trehalose has achieved mass production.
2016–2019
Multi-product development and market development for trehalose applications
2020
Establish a major production base in Northeast China Establish a synthetic biology pilot-scale demonstration base in Liyang
2021
Trehalose Phase I production commences, NMN plant commissioned, cyclodextrin capacity expanded.
2022
Trehalose Phase II goes into production; new polydextrose project is constructed and commissioned.
2023
Trehalose Phase III comes on stream; amino acid production line is renovated and commissioned.
2024
Construction and commissioning of the Phase I 200,000-ton trehalose and compound formulation project in Fujin
Company Highlights
Trehalose, the “Sugar of Life”
With its excellent application performance and a price comparable to that of white sugar, it is poised to become the next starch sugar product with a production scale of one million tons.
High maltose, oligosaccharides
Building the company’s “exclusive code” for delivering sugar solutions.
Functional sugar
Positioning in the synthetic biology sector, with a focus on sugar substitutes, sugar reduction, and raw materials for functional nutrition products.
WeChat Official Account
Contact Us
0519-87171088
Email:sales@ogobiotech.com
Address: No. 17, Kangping Road, Economic Development Zone, Liyang City, Jiangsu Province
Copyright © 2026 Jiangsu Aogu Biotechnology Co., Ltd. All Rights Reserved.